NY-based VC firm, JLS, invests in tech and psychedelic medicines for wellness and healing.
Location
New York City, NY, US
Founded
2019
JLS is an NY-based venture capital firm that focuses on investing in the intersection of science, technology, and neurology, particularly in the development of plant-based and psychedelic medicines aimed at treating mental and physical conditions. They typically participate in Seed, Series A, and Series B funding rounds, supporting companies that are developing innovative drugs and enabling technologies to enhance therapeutic delivery.
Notable portfolio companies include Fluence, Gilgamesh Pharmaceuticals, Psilera, and Tripp. JLS's investment philosophy centers on leveraging the potential of psychedelics and technology to promote wellness and healing. The firm provides unique value-add services such as strategic guidance and industry connections to help portfolio companies accelerate their growth and impact.
JLS - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
